Fresenius Medical Care AG (FMS) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase plannedPRNewsWire • 01/09/26
Reasons to Hold Fresenius Medical Stock in Your Portfolio for NowZacks Investment Research • 12/11/25
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management BoardPRNewsWire • 12/10/25
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025PRNewsWire • 11/04/25
Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025PRNewsWire • 10/30/25
Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care EnablementPRNewsWire • 10/01/25
Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segmentPRNewsWire • 09/18/25
Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation frameworkPRNewsWire • 08/11/25
Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025PRNewsWire • 08/05/25
Is the Options Market Predicting a Spike in Fresenius Medical Stock?Zacks Investment Research • 07/29/25